Metropolitan Life Insurance CO Liquidia Corp Transaction History

Metropolitan Life Insurance CO

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$6.63 - $9.9 $5,827 - $8,702	879 Added 50.03%	2,636 $20,000
Q1 2023 May 15, 2023	SELL	$5.72 - $7.91 $7,310 - $10,108	-1,278 Reduced 42.11%	1,757 $12,000
Q4 2022 Jun 14, 2023	BUY	$4.68 - $6.54 $5,981 - $8,358	1,278 Added 72.74%	3,035 $19.3 Million
Q4 2022 Mar 30, 2023	BUY	$4.68 - $6.54 $9,350 - $13,066	1,998 Added 192.67%	3,035 $19,000
Q4 2022 Feb 15, 2023	BUY	$4.68 - $6.54 $9,350 - $13,066	1,998 Added 192.67%	3,035 $19,000
Q3 2022 Jun 14, 2023	SELL	$3.73 - $8.39 $2,685 - $6,040	-720 Reduced 40.98%	1,037 $5.64 Million
Q3 2022 Mar 30, 2023	SELL	$3.73 - $8.39 $7,206 - $16,209	-1,932 Reduced 65.07%	1,037 $5,000
Q3 2022 Nov 14, 2022	SELL	$3.73 - $8.39 $7,206 - $16,209	-1,932 Reduced 65.07%	1,037 $6,000
Q2 2022 Jun 20, 2023	BUY	$3.37 - $7.55 $4,084 - $9,150	1,212 Added 68.98%	2,969 $12,000
Q2 2022 Mar 30, 2023	SELL	$3.37 - $7.55 $14,302 - $32,042	-4,244 Reduced 58.84%	2,969 $12,000
Q2 2022 Aug 11, 2022	BUY	$3.37 - $7.55 $10,005 - $22,415	2,969 New	2,969 $13,000
Q3 2020 Nov 13, 2020	SELL	$4.34 - $8.28 $31,304 - $59,723	-7,213 Closed	0 $0
Q2 2020 Jun 26, 2023	BUY	$4.86 - $11.44 $26,516 - $62,416	5,456 Added 310.53%	7,213 $60,000
Q2 2020 Mar 30, 2023	BUY	$4.86 - $11.44 $20,305 - $47,796	4,178 Added 137.66%	7,213 $60,000
Q2 2020 Aug 14, 2020	BUY	$4.86 - $11.44 $35,055 - $82,516	7,213 New	7,213 $61,000

162

36M

1.79M

380K

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $709M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.